Sulfonylamino-benzene derivatives (A), as pure stereoisomers (particularly enantiomers or diastereomers), racemates or mixtures in any proportions, optionally as salts and/or solvates are new. Sulfonylamino-benzene derivatives of formula (A), as pure stereoisomers (particularly enantiomers or diastereomers), racemates or mixtures in any proportions, optionally as salts and/or solvates are new. X : O, S or -NCN； Y : amino, NHR 30>；, NR 31>；R 32>；, or (un)saturated optionally substituted (OS) 1-10C aliphatic group； n : 0-4； R 1>；-R 4>；H, F, Cl, Br, I, SF 5, nitro, CF 3, CN, amino, OH, SH, CONH 2, SO 2NH 2, CONHOH, COOH, CHO, SO 2OH, NHR 11>；, NR 12>；R 13>；, OR 14>；, SR 15>；, CONHR 16>；, CONR 17>；R 18>；, SO 2NHR 19>；, SO 2NR 20>；R 21>；, COOR 22>；, COR 23>；, SOR 24>；, SO 2R 24>； or (un) saturated OS 1-10C aliphatic group； R 5>；R 1>；, CF 2Cl, or (un)saturated OS 3-9 membered cycloaliphatic ring, attached via C atom, optionally including 1 or more heteroatoms in the ring； either Q : a group of formula (a)-(g)； R 6>；, R 7>；, R 9>；R 1>；, CF 2Cl, or OS 6-10 membered aryl, optionally attached via OS 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene； R 8>；R 1>；, CF 2Cl, amidino, C(=NH)-NHR 27>；, guanidino, or N=C(NHR 28>；)(NHR 29>；)； or (un)saturated OS 3-9 membered cycloaliphatic ring, attached via C atom, optionally including 1 or more heteroatoms in the ring, optionally fused with (un)saturated OS mono- or poly-cyclic ring system and/or attached via OS 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene； or OS 5-14 membered (hetero)aryl group, optionally fused with (un)saturated OS mono- or poly-cyclic ring system and/or attached via OS 1-6C alkylene, 2-6C alkenylene or 2-6C alkynylene； R 10>；SF 5, nitro, CF3, CF2Cl, CN, amino, OH, SH, CONH2, SO2NH2, CONHOH, COOH, CHO, SO 2OH, NHR 11>；, NR 12>；R 13>；, OR 14>；, SR 15>；, CONHR 16>；, CONR 17>；R 18>；, SO 2NHR 19>；, SO 2NR 20>；R 21>；, COOR 22>；
